Suppr超能文献

人类癌症中的治疗性微小RNA

Therapeutic microRNAs in human cancer.

作者信息

Ors-Kumoglu Gizem, Gulce-Iz Sultan, Biray-Avci Cigir

机构信息

Department of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey.

Biomedical Technologies Graduate Programme, Institute of Natural and Applied Sciences, Ege University, Izmir, Turkey.

出版信息

Cytotechnology. 2019 Feb;71(1):411-425. doi: 10.1007/s10616-018-0291-8. Epub 2019 Jan 1.

Abstract

MicroRNAs (miRNAs) are RNA molecules at about 22 nucleotide in length that are non-coding, which regulate gene expression in the post-transcriptional level by performing degradation or blocks translation of the target mRNA. It is known that they play roles in mechanisms such as metabolic regulation, embryogenesis, organogenesis, differentiation and growth control by providing post-transcriptional regulation of gene expression. With these properties, miRNAs play important roles in the regulation of biological processes such as proliferation, differentiation, apoptosis, drug resistance mechanisms in eukaryotic cells. In addition, there are miRNAs that can be used for cancer therapy. Tumor cells and tumor microenvironment have different miRNA expression profiles. Some miRNAs are known to play a role in the onset and progression of the tumor. miRNAs with oncogenic or tumor suppressive activity specific to different cancer types are still being investigated. This review summarizes the role of miRNAs in tumorigenesis, therapeutic strategies in human cancer and current studies.

摘要

微小RNA(miRNA)是长度约为22个核苷酸的非编码RNA分子,其通过降解靶mRNA或阻断其翻译在转录后水平调控基因表达。已知它们通过提供基因表达的转录后调控,在代谢调节、胚胎发生、器官发生、分化和生长控制等机制中发挥作用。凭借这些特性,miRNA在真核细胞的增殖、分化、凋亡、耐药机制等生物过程的调控中发挥重要作用。此外,还有可用于癌症治疗的miRNA。肿瘤细胞和肿瘤微环境具有不同的miRNA表达谱。已知一些miRNA在肿瘤的发生和发展中起作用。针对不同癌症类型具有致癌或抑癌活性的miRNA仍在研究中。本综述总结了miRNA在肿瘤发生中的作用、人类癌症的治疗策略及当前研究情况。

相似文献

1
Therapeutic microRNAs in human cancer.
Cytotechnology. 2019 Feb;71(1):411-425. doi: 10.1007/s10616-018-0291-8. Epub 2019 Jan 1.
2
miRNA and cancer; computational and experimental approaches.
Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335.
5
The Dual Role of MicroRNAs in Colorectal Cancer Progression.
Int J Mol Sci. 2018 Sep 17;19(9):2791. doi: 10.3390/ijms19092791.
6
MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Methods Mol Biol. 2018;1699:23-43. doi: 10.1007/978-1-4939-7435-1_2.
7
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 2011 May;47(8):1127-37. doi: 10.1016/j.ejca.2011.02.008. Epub 2011 Mar 12.
8
Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy.
Apoptosis. 2014 Aug;19(8):1177-89. doi: 10.1007/s10495-014-0999-7.
9
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.
Mol Aspects Med. 2019 Dec;70:3-20. doi: 10.1016/j.mam.2018.07.003. Epub 2018 Aug 18.
10
Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
ACS Chem Biol. 2014 Mar 21;9(3):711-21. doi: 10.1021/cb400668h. Epub 2014 Jan 3.

引用本文的文献

1
A Multimodal Therapeutic Strategy for Inflammatory Bowel Disease Using MicroRNA-146a Mimic Encapsulated in Lipid Nanoparticles.
Mol Pharm. 2025 Jun 2;22(6):3132-3141. doi: 10.1021/acs.molpharmaceut.5c00014. Epub 2025 May 5.
2
STK33 as the functional substrate of miR-454-3p for suppression and apoptosis in neuroblastoma.
Mol Cells. 2024 Dec;47(12):100145. doi: 10.1016/j.mocell.2024.100145. Epub 2024 Nov 6.
3
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma.
Int J Mol Sci. 2024 Feb 20;25(5):2464. doi: 10.3390/ijms25052464.
4
Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate in Triple Negative Breast Cancer.
Endocr Metab Immune Disord Drug Targets. 2024;24(14):1664-1676. doi: 10.2174/0118715303289859240214103350.
5
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
BMC Cancer. 2023 Sep 12;23(1):857. doi: 10.1186/s12885-023-11365-5.
6
Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways.
Ann Hematol. 2024 May;103(5):1455-1482. doi: 10.1007/s00277-023-05383-3. Epub 2023 Aug 1.
7
miRacle of microRNA-Driven Cancer Nanotherapeutics.
Cancers (Basel). 2022 Aug 6;14(15):3818. doi: 10.3390/cancers14153818.
8
9
Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer.
PLoS One. 2022 Aug 3;17(8):e0272308. doi: 10.1371/journal.pone.0272308. eCollection 2022.
10
Local Anesthetic Ropivacaine Exhibits Therapeutic Effects in Cancers.
Front Oncol. 2022 Feb 3;12:836882. doi: 10.3389/fonc.2022.836882. eCollection 2022.

本文引用的文献

2
Increased levels of serum miR-148a-3p are associated with prostate cancer.
APMIS. 2018 Sep;126(9):722-731. doi: 10.1111/apm.12880.
5
miR-15a/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-β signaling pathway.
Biomed Pharmacother. 2018 Aug;104:637-644. doi: 10.1016/j.biopha.2018.05.041. Epub 2018 May 25.
6
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.
Sci Rep. 2018 May 18;8(1):7820. doi: 10.1038/s41598-018-26050-y.
8
Anticancer effect of miR-96 inhibitor in bladder cancer cell lines.
Oncol Lett. 2018 Mar;15(3):3814-3819. doi: 10.3892/ol.2018.7745. Epub 2018 Jan 8.
9
miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
Oncol Rep. 2018 Apr;39(4):1649-1657. doi: 10.3892/or.2018.6259. Epub 2018 Feb 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验